p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression

Sviderskaya, EV; Gray-Schopfer, VC; Hill, SP; Smit, NP; Evans-Whipp, Tracy; Bond, J; Hill, L; Bataille, V; Peters, G; Kipling, D; Wynford-Thomas, D; Bennett, DC

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression

journal contribution

posted on 2025-05-30, 18:33 authored by EV Sviderskaya, VC Gray-Schopfer, SP Hill, NP Smit, Tracy Evans-WhippTracy Evans-Whipp, J Bond, L Hill, V Bataille, G Peters, D Kipling, D Wynford-Thomas, DC Bennett

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression

History

Journal

Journal of the National Cancer Institute

Volume

95

Pagination

723-732

Location

United States

ISSN

0027-8874

eISSN

1460-2105

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

10

Publisher

Oxford University Press (OUP)

Usage metrics

Keywords

Apoptosis Cell Line, Transformed Cellular Senescence Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p21 Cyclins DNA-Binding Proteins Disease Progression Gene Expression Regulation, Neoplastic Humans Immunoblotting Karyotyping Kinetics Melanocytes Melanoma Phenotype Telomerase

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression

History

Journal

Volume

Pagination

Location

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports